Wegovy lawsuit

Wegovy®, a weight loss drug, has been associated with significant health complications, notably gastroparesis, or stomach paralysis. This association has led to the filing of Wegovy lawsuits by affected individuals seeking compensation for their injuries.

Wegovy is an injectable weight loss medication, containing semaglutide as its active ingredient. This compound works by decelerating the digestion process, which in turn, makes users feel satiated for extended periods. However, when gastric emptying is excessively slowed down, it can lead to severe health issues, including stomach paralysis.

According to the Journal of the American Medical Association, semaglutide-based drugs like Wegovy have a higher likelihood of being linked with gastroparesis and other gastrointestinal complications compared to other weight loss drugs.

Patients’ ability to make informed decisions about their health is contingent upon receiving adequate information about the potential risks associated with their medications. Regrettably, numerous patients have expressed concerns that they were not sufficiently warned about specific side effects of Wegovy.

The serious side effects that may accompany the use of Wegovy include, but are not limited to, gastroparesis, bowel or intestinal obstructions, chronic vomiting, deep vein thrombosis (DVT), esophageal injury, ileus (intestinal inability to contract and pass waste), intraoperative pulmonary aspiration, malnutrition-related disorders, and pancreatic cancer.

The aftermath of gastroparesis and other injuries caused by Wegovy has left many users grappling with health complications and burdensome medical bills. If you have suffered severe side effects after using Wegovy, our team may be able to help you secure compensation to cover treatment costs and other related expenses. It is our mission to ensure that you are not left to bear the brunt of a situation that was not of your making.